Advertisement
Advertisement

LLY

LLY logo

Eli Lilly & Co.

1057.99
USD
Sponsored
+37.15
+3.64%
Feb 06, 15:59 UTC -5
Closed
exchange

After-Market

1068.53

+10.54
+1.00%

LLY Earnings Reports

Positive Surprise Ratio

LLY beat 28 of 40 last estimates.

70%

Next Report

Date of Next Report
Apr 30, 2026
Estimate for Q1 26 (Revenue/ EPS)
$17.40B
/
$7.68
Implied change from Q4 25 (Revenue/ EPS)
-9.81%
/
+1.86%
Implied change from Q1 25 (Revenue/ EPS)
+36.70%
/
+129.94%

Eli Lilly & Co. earnings per share and revenue

On Feb 04, 2026, LLY reported earnings of 7.54 USD per share (EPS) for Q4 25, beating the estimate of 6.73 USD, resulting in a 11.92% surprise. Revenue reached 19.29 billion, compared to an expected 18.14 billion, with a 6.36% difference. The market reacted with a +10.33% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 12 analysts forecast an EPS of 7.68 USD, with revenue projected to reach 17.40 billion USD, implying an increase of 1.86% EPS, and decrease of -9.81% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
ABBVIE INC.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$2.70
Actual
$2.71
Surprise
+0.17%
logo
Novartis AG
Report Date
Feb 04, 2026 For Q4 25
Estimate
$2.02
Actual
$2.02
Surprise
+0.27%
logo
Merck & Co., Inc.
Report Date
Feb 03, 2026 For Q4 25
Estimate
$2.02
Actual
$2.04
Surprise
+0.52%
logo
Novo-Nordisk A/S
Report Date
Feb 04, 2026 For Q4 25
Estimate
$5.97
Actual
$6.32
Surprise
+5.77%
logo
Pfizer Inc.
Report Date
Feb 03, 2026 For Q4 25
Estimate
$0.57
Actual
$0.66
Surprise
+14.29%
logo
Sanofi - ADR
Report Date
Jan 29, 2026 For Q4 25
Estimate
$1.46
Actual
$1.53
Surprise
+4.22%
FAQ
For Q4 2025, Eli Lilly & Co. reported EPS of $7.54, beating estimates by 11.92%, and revenue of $19.29B, 6.36% above expectations.
The stock price moved up 10.33%, changed from $1.00K before the earnings release to $1.11K the day after.
The next earning report is scheduled for Apr 30, 2026.
Based on 12 analysts, Eli Lilly & Co. is expected to report EPS of $7.68 and revenue of $17.40B for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement